CDC Issues Interim Guidance for Prioritizing Oseltamivir in Influenza Treatment
The issue appears to be related to the availability of generic oseltamivir.
The issue appears to be related to the availability of generic oseltamivir.
Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, the tripledemic of RSV, COVID-19, and influenza continues throughout the holiday season.
Toolkit provides guidance on the COVID-19 bivalent booster and oral antiviral therapeutics.
Lee EH, Lee KH, Kim J, et al. Comparing different delivery methods of fecal microbiota transplantation. Presented at: IDWeek 2022; October 19-23, 2022; Washington, DC. Poster 515.
NFID survey show beliefs about influenza and pneumococcal disease, as well as attitudes and practices around vaccination, including the impacts of the COVID-19 pandemic.
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
The AAP recommends annual vaccination against influenza for all children without medical contraindications, starting at age 6 months.
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.
COVID-19 research is expected to yield medical and scientific dividends for the treatment of influenza, cancer, cystic fibrosis, and other chronic diseases.
Although the facts in this month’s Legal Advisor predate the COVID-19 pandemic, the legal impact is likely to be relevant in cases that involve religious exemption for mandatory vaccines.